Abstract
References
Articles referenced by this article (19)
Immunochemical similarity between polysaccharide antigens of Escherichia coli 07: K1(L):NM and group B Neisseria meningitidis.
J Immunol, (1):262-268 1973
MED: 4346607
Immunologic response of man to group B meningococcal polysaccharide vaccines.
J Infect Dis, (5):514-521 1972
MED: 4197754
Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates
J Immunol 1982
Class-specific antibody response to group B Neisseria meningitidis capsular polysaccharide: use of polylysine precoating in an enzyme-linked immunosorbent assay.
Infect Immun, (3):1203-1207 1982
MED: 6818147
Enhancement of immunologic activity by noncovalent complexing of meningococcal group B polysaccharide and outer membrane proteins
1982
Immunity and protection of mice against Neisseria meningitidis group B by vaccination, using polysaccharide complexed with outer membrane proteins: a comparison with purified B polysaccharide.
Infect Immun, (2):527-533 1985
MED: 3917979
Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis.
Lancet, (8346):355-357 1983
MED: 6135869
Cleavage of the polysialosyl units of brain glycoproteins by a bacteriophage endosialidase. Involvement of a long oligosaccharide segment in molecular interactions of polysialic acid.
J Biol Chem, (2):1265-1270 1985
MED: 3968060
The Escherichia coli K1 capsule shares antigenic determinants with the human gangliosides GM3 and GD3.
N Engl J Med, (11):726-727 1984
MED: 6199668
Levels of plasma proteins in human and rat fetal CSF and the development of the blood-CSF barrier
Neuropaediatrics 1977
Show 9 more references (10 of 19)
Citations & impact
Impact metrics
Article citations
The β-reducing end in α(2-8)-polysialic acid constitutes a unique structural motif.
Glycobiology, 27(9):900-911, 01 Sep 2017
Cited by: 6 articles | PMID: 28369425 | PMCID: PMC6283323
Capsular polysaccharide vaccine for Group B Neisseria meningitidis, Escherichia coli K1, and Pasteurella haemolytica A2.
Proc Natl Acad Sci U S A, 108(44):17871-17875, 24 Oct 2011
Cited by: 19 articles | PMID: 22025709 | PMCID: PMC3207679
Extracellular structure of polysialic acid explored by on cell solution NMR.
Proc Natl Acad Sci U S A, 104(28):11557-11561, 03 Jul 2007
Cited by: 25 articles | PMID: 17609375 | PMCID: PMC1906721
Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005.
Vaccine, 24(24):5093-5107, 01 Jun 2006
Cited by: 125 articles | PMID: 16838413
Are antibodies to the capsular polysaccharide of Neisseria meningitidis group B and Escherichia coli K1 associated with immunopathology?
Vaccine, 24(3):221-228, 11 Aug 2005
Cited by: 28 articles | PMID: 16125824
Review
Go to all (10) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis.
Lancet, 2(8346):355-357, 01 Aug 1983
Cited by: 418 articles | PMID: 6135869
Bactericidal activity of two IgG2a murine monoclonal antibodies with distinct fine specificities for group B Neisseria meningitidis capsular polysaccharide.
Hybridoma, 11(6):677-687, 01 Dec 1992
Cited by: 10 articles | PMID: 1284118
A human monoclonal macroglobulin with specificity for alpha(2----8)-linked poly-N-acetyl neuraminic acid, the capsular polysaccharide of group B meningococci and Escherichia coli K1, which crossreacts with polynucleotides and with denatured DNA.
J Exp Med, 164(2):642-654, 01 Aug 1986
Cited by: 85 articles | PMID: 3088209 | PMCID: PMC2188242
The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
Contrib Microbiol Immunol, 10:151-165, 01 Jan 1989
Cited by: 5 articles | PMID: 2479499
Review